TSLA360.590-20.67001%
GM72.540-2.5%
F11.590-0.09%
RIVN15.4000.46%
CYD39.410-0.08%
HMC24.150-0.16%
TM207.010-2.66%
CVNA313.5481.45799%
PAG149.3400.18%
LAD251.8201%
AN197.680-0.29%
GPI329.450-1.34%
ABG194.7600.73%
SAH64.870-0.38%
TSLA360.590-20.67001%
GM72.540-2.5%
F11.590-0.09%
RIVN15.4000.46%
CYD39.410-0.08%
HMC24.150-0.16%
TM207.010-2.66%
CVNA313.5481.45799%
PAG149.3400.18%
LAD251.8201%
AN197.680-0.29%
GPI329.450-1.34%
ABG194.7600.73%
SAH64.870-0.38%
TSLA360.590-20.67001%
GM72.540-2.5%
F11.590-0.09%
RIVN15.4000.46%
CYD39.410-0.08%
HMC24.150-0.16%
TM207.010-2.66%
CVNA313.5481.45799%
PAG149.3400.18%
LAD251.8201%
AN197.680-0.29%
GPI329.450-1.34%
ABG194.7600.73%
SAH64.870-0.38%


DLA

objections

Overcoming Objections (Part 6)

- October 16, 2017
In part 6 of a 10-part series on overcoming objections, David teaches you how to use DLA's structured objection response process to deal with the most common objections you'll be...


CBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.